Astrazeneca to invest $2bn in Summit Therapeutics, AG Barr backs FY expectations

STOCKS TO WATCHAstrazeneca will invest $2bn in US biopharma Summit Therapeutics, the British drugs giant confirmed on Tuesday. Under the terms of the deal, Astrazeneca will buy newly-issued equity in the New York-listed oncology specialist, giving it a stake of around 12%. The tie-up will allow the…